Molecular pathways that drive diabetic kidney disease

S Mohandes, T Doke, H Hu, D Mukhi… - The Journal of …, 2023 - Am Soc Clin Investig
Kidney disease is a major driver of mortality among patients with diabetes and diabetic
kidney disease (DKD) is responsible for close to half of all chronic kidney disease cases …

[HTML][HTML] Clinical relevance of globotriaosylceramide accumulation in Fabry disease and the effect of agalsidase beta in affected tissues

C Tøndel, BL Thurberg, P DasMahapatra, N Lyn… - Molecular Genetics and …, 2022 - Elsevier
Fabry disease (FD) is a rare lysosomal storage disorder, characterized by a reduction in α-
galactosidase A enzyme activity and the progressive accumulation of globotriaosylceramide …

Unbiased human kidney tissue proteomics identifies matrix metalloproteinase 7 as a kidney disease biomarker

D Hirohama, A Abedini, S Moon… - Journal of the …, 2023 - journals.lww.com
Background Diabetic kidney disease (DKD) is responsible for close to half of all ESKD
cases. Although unbiased gene expression changes have been extensively characterized in …

Spatially resolved human kidney multi-omics single cell atlas highlights the key role of the fibrotic microenvironment in kidney disease progression

A Abedini, J Levinsohn, KA Klötzer, B Dumoulin, Z Ma… - bioRxiv, 2022 - biorxiv.org
Kidneys possess one of the most intricate three-dimensional cellular structures in the body,
yet the spatial and molecular principles of kidney health and disease remain inadequately …

Unraveling the epigenetic code: human kidney DNA methylation and chromatin dynamics in renal disease development

Y Yan, H Liu, A Abedini, X Sheng, M Palmer… - nature …, 2024 - nature.com
Epigenetic changes may fill a critical gap in our understanding of kidney disease
development, as they not only reflect metabolic changes but are also preserved and …

Circulating activin A, kidney fibrosis, and adverse events

MT Tsai, SM Ou, KH Lee, CC Lin… - Clinical Journal of the …, 2023 - journals.lww.com
Background: Identification of reliable biomarkers to assess kidney fibrosis severity is
necessary for patients with chronic kidney disease (CKD). Activin A, a member of the TGF-β …

Kidney biopsy-based epidemiologic analysis shows growing biopsy rate among the elderly

A Molnár, MJ Thomas, A Fintha, M Kardos, D Dobi… - Scientific Reports, 2021 - nature.com
Systematic registration and examination of biopsy-related data in Central and Eastern
Europe are scarce, while the health condition of the population is worse compared to other …

Comparative study between variable flip angle and modified Look–Locker inversion recovery for evaluating renal interstitial fibrosis

C Hua, Y Zhuang, M Wang, T Cai, B Xu… - Journal of Magnetic …, 2024 - Wiley Online Library
Background Variable flip angle (VFA) and modified Look–Locker inversion recovery (MOLLI)
are frequently used for noninvasive evaluation of renal interstitial fibrosis (IF) in chronic …

Predicting CKD progression using time-series clustering and light gradient boosting machines

H Saito, H Yoshimura, K Tanaka, H Kimura… - Scientific Reports, 2024 - nature.com
Predicting the transition of kidney function in chronic kidney disease is difficult as specific
symptoms are lacking and often overlooked, and progress occurs due to complicating …

Prognostic implications of a morphometric evaluation for chronic changes on all diagnostic native kidney biopsies

A Denic, M Bogojevic, AF Mullan, M Sabov… - Journal of the …, 2022 - journals.lww.com
Background Semiquantitative visual inspection for glomerulosclerosis, interstitial fibrosis,
and arteriosclerosis is often used to assess chronic changes in native kidney biopsies …